Table 3. Percentage of patients treated with each antimicrobial drug used against gonorrhea in South Korea, 2010–2017.
| Year | % Patients |
|||||
|---|---|---|---|---|---|---|
| Fluoroquinolones* | Spectinomycin | Ceftriaxone | Cefixime | Other cephalosporin | Penicillin G | |
| 2010 | 49.6 | 32.8 | 13.1 | 2.9 | 1.4 | 0.2 |
| 2011 | 51.4 | 29.2 | 14.6 | 3.7 | 0.8 | 0.2 |
| 2012 | 52.3 | 22.2 | 19.5 | 4.6 | 1.2 | 0.2 |
| 2013 | 47.0 | 23.9 | 23.1 | 4.6 | 1.3 | 0.2 |
| 2014 | 38.8 | 22.0 | 20.3 | 3.9 | 1.1 | 0.1 |
| 2015 | 39.3 | 17.7 | 23.0 | 4.5 | 1.1 | 0.1 |
| 2016 | 36.7 | 17.3 | 24.7 | 5.0 | 1.4 | 0.1 |
| 2017 | 26.7 | 16.0 | 30.5 | 6.6 | 1.7 | 0.1 |
*Mainly ciprofloxacin.